It is well known that the toxicokinetics (i.e. absorption, distribution, metabolism and excretion) of mercury is highly dependent on the form of mercury to which a receptor has been exposed. The aim of this paper is to summarize the available health effects information for mercury and mercury compounds in the international scientific literature and to point to the need for increased Hg control of water and food, including mercury speciation, especially in Mediterranean countries.
INTRODUCTION
The toxicity of mercury is well-known for centuries. The first report pertaining to the toxicity of this metal and its compounds is probably in the works of Plenius Senior (23-79 A.D.) (Huber, 1997) . During the Roman Empire, slavery at the Cinnabar mines was used as a terrible punishment for "disobedient" citizens. This was amounting to a slow, painful death (Pavlogeorgatos, 2001) . The first description of industrial poisoning from mercury use is found in 1557. The workers suffered from chronic exposure to inorganic mercury salt, which resulted in restlessness, depression, lack of concentration and the characteristic hand tremor (Pavlogeorgatos, 2001) .
Centuries later in Lewis Caroll's "Alice in wonderland" the existence of mad hatters is mentioned (19 century A.C.), whose insanity was caused by the use of mercury nitrate solutions which were used to the cleaning of felt hats and the processing of beaver pelts which were in fashion at that time for hat-making (Shrader and Hobbins, 1983) . This insanity was usually accompanied by a "curious gait", hand tremor, depression, tachycardia, concentration loss etc. The expression "mad as a hatter", was a result of the connection of this particular professional class to the neurological disturbance that is brought by inorganic mercury salt exposure. In modern history, mass poisonings by mercury compounds in many countries (US EPA, 1997b; Forstner -Wittmann, 1983) , as for example in Japan on 1950 , 1964 in Iraq on 1972 and in Canada in 1978 the scientific community to the intensification of research of the toxic effect of mercury to the living and non-living environment. Despite the fact that mercury is one of the most toxic metals with serious effects on humans and on the environment, its research was seriously delayed, compared to other metals. This could be explained by the following: Mercury's ability to exist in several physical states and chemical forms at commonly -encountered conditions of temperature and pressure, and its propensity to undergo biological transformations, means that it is subject to complex and difficultto-predict changes in concentration and form. Environmental monitoring studies thus must consider a variety of physical changes, geochemical reactions, and biochemical interactions in an attempt to understand the specific local conditions that contribute to mercury levels found in different environmental media and living things. Mercury is a List I (EEC, 1976) substance and its presence in effluents is controlled by two EEC Directives (EEC, 1982; EEC, 1984) . All scientists who have studied mercury's behaviour, during the last decade, have faced the following problems (Pavlogeorgatos, 2001) : • Mercury has high detection limits in the most widely used analytical techniques used for the determination of heavy metals (AAS, ICP-AES). • Serious contamination problems come up during the sampling, the pre-treatment and the analysis of samples. • There is a lack of mercury concentrations in some of the existing reference materials. So, the purposes of this paper are: 1. The survey of the scientific literature (from 1940 to 2003) relating to the effects of different mercury species on the human health.
To show the inadequacy of the current
European legislation to protect the human health, as much as the environment, from mercury. 3. To indicate the need for increased mercurydetection controls in water and in food especially in the Mediterranean countries. The inhabitants of these countries belong to a high-risk population for exposure to mercury.
SOURCES OF MERCURY IN THE ENVIRONMENT
The main sources of mercury in the environment are presented in Table 1 .
High-risk groups for mercury exposure High-risk groups according to their mercury exposure are mainly: 1. Industrial workers (Limbong et al., 2003; Vahter et al., 2002; US EPA, 1997; Piikivini and Hanninen, 1989; Piikivini and Tolonen, 1989; Miller et al., 1975; Barregard et al., 1992; Langolf et al., 1978; Forzi et al., 1978) 2. People living near point sources of mercury emissions (Pavlogeorgatos, 2001; US EPA, 1997) . 3. People who consume large amounts of fish (Watanabe et al., 2003; Jewett et al., 2003; Lopez -Alonso et al., 2003; Tsuji and Robinson, 2002; Vahter et al., 2002; Davis et al., 2002; Santos et al., 2002; Sanna et al., 2002; Mergler, 2002; Boischio and Henshel, 2000; Airey, 1983) . 4. Dental professionals (Sanna et al., 2002; Hol et al., 2001; US EPA, 1997) . 5. Chemists and chemical laboratories stuff (Pavlogeorgatos, 2001; Dewhurst, 1974) . In Figure 1 is shown the geographical distribution of Mediterranean mines, which produce the largest quantities of mercury in the world. This fact, together with the fact that Mediterranean inhabitants belong to high-risk groups for mercury exposure 2 and 3, leads to the conclusion that South Europeans are among the most highly exposed to mercury compounds.
Toxicokinetics of mercury in humans
Mercury toxicity is caused, mainly, by the fact that it enters the living organism, and reacts with different enzymes inhibiting the catalysis of basic metabolic reactions (WHO, 1990; Public Health Statement, 1990; WHO, 1989; Kouimtzis, 1994) . The general population may be exposed to mercury compounds through inhalation of ambient air; consumption of contaminated food, water or soil; and/or dermal exposure to substances containing mercury. In addition, some quantity of mercury is released from dental amalgam. It is well known that the toxicokinetics (i.e. absorption, distribution, metabolism and excretion) of mercury are highly dependent on the form of mercury to which a receptor has been exposed Table 1 . Sources of mercury in the environment (Lopez Alonso et al., 2003; Freed et al., 2002; Sanna et al., 2002; Ansari et al., 1999; US EPA, 1997a and b; Obenauf and Skavroneck, 1997; Huber, 1997; Namasivayam and Periasamy, 1993; Jasinski, 1994; US EPA, 1992b; Lester, 1987; Nurnberg, 1985; WHO, 1989) . (US EPA, 1997). As a result we must approach differently the toxicokinetics of each form of mercury in the human organism according to:
• Absorption (Table 2) • Excretion (Table 3) • Distribution (Table 4) • Biological action (Table 5) • Affected organs (Table 6) • Detoxification and suppression (Table 7) , and
• Borderline concentrations of different Hg forms in the human body (Table 8 ). On Table 9 the latest data on hazard identification and dose-response assessment are summarized, according to the U.S. EPA. Finally on Table 10 the effects of mercury compounds on human health are summarized according to the international scientific literature (from 1940 to 2003) . The respiratory absorption of elemental mercury is the major way of absorption in humans (>75-85% of the total uptake). Through the lungs it is eventually transported to the bloodstream. Gastrointestinal tract absorption is negligible (0.01%).
The degree of absorption of inorganic mercury by the gastrointestinal tract varies, and depends on which mercuric salt is involved in this process (7-15%).
Absorption diminishes with the decrease in solubility. Estimates on the degree of uptake of inorganic mercury vary, though it is greater than 20% of the total Hg uptake. In general, bivalent Hg, because it has a greater solubility than the univalent, is more absorbed and more toxic. There is no data about dermal absorption.
Methyl-mercury is rapidly and in a large degree absorbable (95%) by the gastrointestinal system. Information pertaining to the inspiratory absorption of this compound is limited. The percentage of dermal absorption is unknown (3-5% in laboratory animals).
There is a small amount of absorption by the respiratory and dermal system, and complete absorption by the gastrointestinal system (this is true for acetic phenyl-mercury and less so for methoxy-ethyl-mercury).
CONCLUSIONS
As Tables 1-10 indicate the main conclusions of this report are: 1. Mercury causes serious damages to the human organism, mainly of a neurological nature, which can even lead to the death of the exposed individual. The severity of these damages depends on the quantity acquired, the duration of the exposure and the chemical species of mercury. 2. The inhabitants of the Mediterranean basin belong to the high-risk groups for exposure to different forms of mercury, because of their dietary habits and their proximity to natural mercury sources. 3. The current European legislation sets the maximum allowed limits for total mercury concentration in drinkable water and in food (mainly of sea origin), but does not demand the chemical speciation of the detected mercury. Also, it should be mentioned, that in many Mediterranean countries the food and water control for mercury detection is negligent and occasional, because mercury detection demands additional equipment, specialized staff and meticulous care in sampling and analysis. Other organic Hg compounds.
Elemental Hg is excreted from the human body in the urine, feces, expired air, sweat and saliva. Variations of the form of excretion depend on the degree of oxidation of elemental Hg to mercuric mercury. In general, a lowlevel exposure is related to a, mainly, fecal excretion, while a high-level exposure is related to a mainly urinary.
On a low-level exposure, it is excreted mainly by the stool (approximately 85%), while on a high-level exposure mainly by the urine (approximately 35%).
Its clearance from the human organism is accomplished by excretion in stool, maternal milk and urine.
It is the same as the inorganic mercury. It is mainly transported by red blood cells (>98% of the total uptake) and accumulates mainly on the cerebral gray matter (especially the fetal during pregnancy).
It is allocated by bloodstream to the whole human organism and accumulates mainly in liver and kidneys.
Circulates unchanged in the bloodstream for long periods of time. A percentage of the total (about 10%) accumulates in the brain and the placenta of pregnant women. Also in spleen, heart and hair.
Because of their dissociation to bivalent Hg in the liver, it is the same as the inorganic mercury. US ÅPA, 1997c; Hursh et al., 1988; Hursh et al., 1985; Hursh et al., 1976; Nordberg and Serenius, 1969; Takahata et al., 1970 . Vahter et al., 2002 Hac et al., 2000; Newton and Fry, 1978; Rothstein and Hayes, 1960; Cember, 1962; Piotrowski et al., 1975; US ÅPA, 1997c; Piotrowski et al., 1973; Stratis and Zachariades, 1989. Ehrenstein et al., 2002; Vahter et al., 2002; Hac et al., 2000; Iyengar and Rapp, 2001; Clarkson, 1972; Hansen, 1988; Hansen et al., 1989; Nielsen et al., 1994; Soria et al., 1992; Suzuki et al., 1984; US ÅPA, 1997c . US ÅPA, 1997c Pavlogeorgatos, 2001 . Table 5 . Biological action of different forms of mercury in the human body
Forms of mercury Biological action References
Elemental Hg
Inorganic Hg compounds
Alkyl Hg
Other organic Hg compounds It easily enters tissue and red blood cells where is oxidized to bivalent mercury, with the help of a catalase.
Because of its increased chemical relation to the SH-groups, found on protein molecules, it inhibits enzyme action. It has an effect on the metabolism of amino acids in the brain and blocks the functions of cell membrane, because of its chemical relation to the PO 4 -groups. But, there are also reports of a reduction of inorganic mercury compounds to the elemental form of this metal.
Using red blood cells it penetrates the blood-brain barrier, and inhibits the enzyme action of glycolysis and the protein synthesis mechanisms.
It dissociates in the liver to produce bivalent and benzol. Accordingly, it has the same action as inorganic mercury. Halbach and Clarkson, 1978; US ÅPA, 1997c; Stratis and Zachariades, 1989. Dunn et al., 1981; Clarkson and Rohstein, 1964; Sugata and Clarkson, 1979; US ÅPA, 1997c . Ehrenstein et al., 2002 US ÅPA, 1997c; Pavlogeorgatos, 2001 US ÅPA, 1997c Stratis and Zachariades, 1989; Pavlogeorgatos, 2001 . THE IMPORTANCE OF MERCURY DETERMINATION AND SPECIATION TO THE HEALTH Table 6 . Critical organs of the human body in its exposure to different forms of mercury.
Form of mercury Critical organs References
Inorganic Hg compounds
Other organic Hg compounds
In a brief, high-level exposure, the lungs. In a long-term exposure the Central Nervous System (CNS) and especially the brain.
Mainly the kidneys.
Brain and CNS.
In case of a chronic exposure the kidneys and probably the liver. Karimi et al., 2002; Adams et al., 1983; Founds et al., 1987; McFarland and Reigel, 1978; Snodgrass et al., 1981; Sexton et al., 1978; Vroom and Greer, 1972; US ÅPA, 1997c; Stratis and Zachariades, 1989. Vahter et al., 2002; Carrier et al., 2001 (a and b) ; US ÅPA, 1997c; Pavlogeorgatos, 2001; Stratis and Zachariades, 1989. Ehrenstein et al., 2002; Iyengar and Rapp, 2001; US ÅPA, 1997c; Pavlogeorgatos, 2001; Stratis and Zachariades, 1989. US ÅPA, 1997c; Stratis and Zachariades, 1989; Pavlogeorgatos, 2001 . Table 7 . Detoxification and action suppression of different forms of mercury in the human body.
Mercury form Detoxifying compounds References
Inorganic Hg compounds
Other organic Hg compounds
Vitamin E is reported to be a protective agent. Additionally, ethanol reduces the human organism ability for absorption of elemental mercury, possibly by suppressing the activity of the catalase, which oxidizes it to produce bivalent Hg. Tellurium also appears to have a protective role.
Metaltheionin has a protective role. Also various mercury-chelating compounds (e.g. bimercapto-propanol), accelerate its excretion. Finally, it is worth mentioning that selenium seems to have a protective action by binding Hg to HgSe and limiting its acute action on intestine and kidneys. Tellurium also has a protective role.
Evidence from other mammals indicates that selenium has a protective role against organic mercury also. It is reported, without impressive clinical results, that the N-acetyl product of D, L penicilamine accelerates its excretion. Also vitamin E reduces the toxicity and increases survival chances after an exposure to methyl-mercury.
Glutathion probably catalyzes the rapid dissociation of the Hg-C bond. Dunn et al., 1981; Nielsen -Kudsk, 1965; US ÅPA, 1997c; Stratis and Zachariades, 1989; Magos and Webb, 1979; Khayat and Dencker, 1982 , 1984a and b. Hol et al., 2001 Magos and Webb, 1979; US ÅPA, 1997c; Khayat and Dencker, 1984a; Zalups and Cherian, 1992; Stratis and Zachariades, 1989. Hol et al., 2001; Myers et al., 2000; Grandjean, 1992; Ballatori and Clarkson, 1982; Welsh, 1979; US ÅPA, 1997c . US ÅPA, 1997c Fukino et al., 1992; Girardi and Elias, 1991 . A concentration of 6 mg l -1 in the urine causes the appearance of albuminuria. Ingestion of a quantity <1250 mg of salt causes very mild gastrointestinal disturbances. On levels of between 0.2 and 5.1 mg m -3 of atmospheric air no symptoms were reported. US ÅPA, 1997c; Stratis and Zachariades, 1989; Pavlogeorgatos, 2001; Roels et al., 1982; Verbeck et al., 1986 . US ÅPA, 1997c Stratis and Zachariades, 1989; Pavlogeorgatos, 2001 . US ÅPA, 1997c Stratis and Zachariades, 1989; Pavlogeorgatos, 2001 . US ÅPA, 1997c Stratis and Zachariades, 1989; Pavlogeorgatos, 2001 . B: Critical effect is neurological toxicity (hand tremor; increases in memory disturbances; slight subjective and objective evidence of autoimmune dysfunction) in adults. C: Critical effects is renal toxicity resulting from an autoimmune disease caused by the accumulation of a hapten -mercury complex in the glomerular region of the kidneys. D: Data were judged insufficient for calculation of RfC. E: Critical effect is neurological toxicity in progeny of exposed women, RfD calculated using a benchmark dose (10%). F: US EPA categorizes all chemical compounds into five categories according to their connection to carcinogenesis. Ranging from A (proven carcinogenic compounds) to E (proven non-carcinogenic compounds). Growth retardation in exposed children
Hallucinations
Hypertension, tachycardia
Immune system suppression Renzoni et al., 1998; Verschaeve et al., 1976 . Hess, 2002 Lawrence and MacCabe, 2002; Sondreal et al., 2002 . Vahter et al., 2002 Sikorski et al., 1987 Finkelman et al., 2002 Mergler, 2002; Altmann et al., 1998; Snyder and Seelinger, 1976; Amin -Zaki et al., 1974 . DeRouen et al., 2002 Drasch et al., 2001; Harada et al., 1999; Kang-Yum and Oransky, 1992; Roels et al., 1982; Verbeck et al.,1986; Harada, 1978; Derobert and Tara, 1950. Santos et al., 2002; Renzoni et al., 1998; Popescu et al., 1979 . Cinca et al., 1979 . Vahter et al., 2002 Myers et al., 2000; Sikorski et al., 1987 . Mergler, 2002 Myers et al., 2000; Mitsumori et al., 1990; Tamashiro et al., 1984; Bakir et al., 1973; Mitsumori et al., 1981; Troen et al., 1951 . Vahter et al., 2002 Mergler, 2002; Redwood et al., 2001; Myers et al., 2000; Futatsuka et al., 2000; Sondreal et al., 2000; Marsh et al., 1987; Harada, 1978 . Mergler, 2002 DeRouen et al., 2002; US EPA, 1997c . DeRouen et al., 2002 Futatsuka et al., 2000; Bakir et al., 1980; Cinca et al., 1979; Harada, 1978; Bakir et al., 1973 . DeRouen et al., 2002 Bluhm et al., 1992; Snodgrass et al., 1981; Çallee, 1969 Çallee, . Karimi et al., 2002 Cordier et al., 1991; Afonso and DeAlvarez, 1960 . Akagi et al., 2000 . Marsh et al., 1987 Bakir et al., 1980; Bakir et al., 1973; Harada, 1978 . Soni et al., 1992 Fagala and Wigg, 1992; Snodgrass et al., 1981; Hook et al., 1954 . Mattingly et al., 2001 Sondreal et al., 2000 
Restlessness
Up to 55% reduction on human brain weight and volume Walking deficits -Ataxia Santos et al., 2002; Janicki et al., 1987 . Tamashiro et al., 1986 . Davis et al., 1974 . Derobert and Tara, 1950 . Mergler, 2002 DeRouen et al., 2002; Redwood et al., 2001; Clarkson et al., 1976; Nordberg and Strangert, 1976; WHO, 1976. 
